Role of Neurokinin-1 Receptor in the Initiation and Maintenance of Skin Chronic Inflammatory Diseases

Overview

Journal Immunol Res

Specialty Allergy & Immunology

Date 2011 Jul 1

PMID 21717076

Citations 2

Authors

Sherrie J Divito

Adrian E Morelli

Adriana T Larregina

Affiliations

Soon will be listed here.

Abstract

To fulfill its immunologic functions, the skin is richly populated with dendritic cells (DCs), the most potent professional Ag-processing and Ag-presenting cells of the immune system. The immune-stimulatory and tolerogenic functions of skin DCs are regulated by the immune and neuroendocrine systems. Pro-inflammatory neuropeptides like substance P and calcitonin gene-related peptide secreted by cutaneous Aδ and C nerve fibers are the main initiators of neuro-inflammatory responses in the skin. Conversely, anti-inflammatory neuropeptides like the products of cleavage of proopiomelanocortin (α-melanocyte-stimulating hormone and adrenocorticotropic hormone) negatively regulate immune responses in the skin. Likewise, the control of immune responses against stimuli applied to the skin depends on the balance between the release and neutralization of pro-inflammatory and anti-inflammatory neuropeptides, a matter that has been somehow overlooked by the immunology field until recently.

Citing Articles

NK1R antagonist decreases inflammation and metastasis of breast carcinoma cells metastasized to liver but not to brain; phenotype-dependent therapeutic and toxic consequences.

Nizam E, Koksoy S, Erin N Cancer Immunol Immunother. 2020; 69(8):1639-1650.

PMID: 32322911 PMC: 11027630. DOI: 10.1007/s00262-020-02574-z.

Neurokinin-1 Receptor Antagonism Ameliorates Dry Eye Disease by Inhibiting Antigen-Presenting Cell Maturation and T Helper 17 Cell Activation.

Yu M, Lee S, Lee H, Amouzegar A, Nakao T, Chen Y Am J Pathol. 2019; 190(1):125-133.

PMID: 31669306 PMC: 6943374. DOI: 10.1016/j.ajpath.2019.09.020.

References

Misery L . Langerhans cells in the neuro-immuno-cutaneous system. J Neuroimmunol. 1998; 89(1-2):83-7. DOI: 10.1016/s0165-5728(98)00117-9. View

Patak E, Pinto F, Story M, Pintado C, Fleming A, Page N . Functional and molecular characterization of tachykinins and tachykinin receptors in the mouse uterus. Biol Reprod. 2005; 72(5):1125-33. DOI: 10.1095/biolreprod.104.036814. View

Urashima R, Mihara M . Cutaneous nerves in atopic dermatitis. A histological, immunohistochemical and electron microscopic study. Virchows Arch. 1998; 432(4):363-70. DOI: 10.1007/s004280050179. View

Pascual D, McGhee J, Kiyono H, Bost K . Neuroimmune modulation of lymphocyte function--I. Substance P enhances immunoglobulin synthesis in lipopolysaccharide activated murine splenic B cell cultures. Int Immunol. 1991; 3(12):1223-9. DOI: 10.1093/intimm/3.12.1223. View

Peters E, Botchkarev V, Botchkareva N, Tobin D, Paus R . Hair-cycle-associated remodeling of the peptidergic innervation of murine skin, and hair growth modulation by neuropeptides. J Invest Dermatol. 2001; 116(2):236-45. DOI: 10.1046/j.1523-1747.2001.01232.x. View

Zhang Y, Berger A, Milne C, Paige C . Tachykinins in the immune system. Curr Drug Targets. 2006; 7(8):1011-20. DOI: 10.2174/138945006778019363. View

Kotani H, Hoshimaru M, Nawa H, Nakanishi S . Structure and gene organization of bovine neuromedin K precursor. Proc Natl Acad Sci U S A. 1986; 83(18):7074-8. PMC: 386655. DOI: 10.1073/pnas.83.18.7074. View

Croitoru K, Ernst P, Bienenstock J, Padol I, Stanisz A . Selective modulation of the natural killer activity of murine intestinal intraepithelial leucocytes by the neuropeptide substance P. Immunology. 1990; 71(2):196-201. PMC: 1384303. View

Tabarowski Z, Felten S . Noradrenergic and peptidergic innervation of the mouse femur bone marrow. Acta Histochem. 1996; 98(4):453-7. DOI: 10.1016/S0065-1281(96)80013-4. View

10.

Arck P, Handjiski B, Peters E, Peter A, Hagen E, Fischer A . Stress inhibits hair growth in mice by induction of premature catagen development and deleterious perifollicular inflammatory events via neuropeptide substance P-dependent pathways. Am J Pathol. 2003; 162(3):803-14. PMC: 1868104. DOI: 10.1016/S0002-9440(10)63877-1. View

11.

Kavelaars A, Jeurissen F, Von Frijtag Drabbe Kunzel J, van Roijen J, Rijkers G, Heijnen C . Substance P induces a rise in intracellular calcium concentration in human T lymphocytes in vitro: evidence of a receptor-independent mechanism. J Neuroimmunol. 1993; 42(1):61-70. DOI: 10.1016/0165-5728(93)90213-i. View

12.

Arck P, Handjiski B, Kuhlmei A, Peters E, Knackstedt M, Peter A . Mast cell deficient and neurokinin-1 receptor knockout mice are protected from stress-induced hair growth inhibition. J Mol Med (Berl). 2005; 83(5):386-96. DOI: 10.1007/s00109-004-0627-z. View

13.

Mignini F, Streccioni V, Amenta F . Autonomic innervation of immune organs and neuroimmune modulation. Auton Autacoid Pharmacol. 2003; 23(1):1-25. DOI: 10.1046/j.1474-8673.2003.00280.x. View

14.

Staniek V, Misery L, Peguet-Navarro J, Abello J, Doutremepuich J, Claudy A . Binding and in vitro modulation of human epidermal Langerhans cell functions by substance P. Arch Dermatol Res. 1997; 289(5):285-91. DOI: 10.1007/s004030050194. View

15.

Bar-Shavit Z, Goldman R, Stabinsky Y, Gottlieb P, Fridkin M, Teichberg V . Enhancement of phagocytosis - a newly found activity of substance P residing in its N-terminal tetrapeptide sequence. Biochem Biophys Res Commun. 1980; 94(4):1445-51. DOI: 10.1016/0006-291x(80)90581-1. View

16.

METZGAR R, Borowitz M, Jones N, Dowell B . Distribution of common acute lymphoblastic leukemia antigen in nonhematopoietic tissues. J Exp Med. 1981; 154(4):1249-54. PMC: 2186493. DOI: 10.1084/jem.154.4.1249. View

17.

Santoni G, Perfumi M, Spreghini E, Romagnoli S, Piccoli M . Neurokinin type-1 receptor antagonist inhibits enhancement of T cell functions by substance P in normal and neuromanipulated capsaicin-treated rats. J Neuroimmunol. 1999; 93(1-2):15-25. DOI: 10.1016/s0165-5728(98)00173-8. View

18.

Lai J, Douglas S, Ho W . Human lymphocytes express substance P and its receptor. J Neuroimmunol. 1998; 86(1):80-6. DOI: 10.1016/s0165-5728(98)00025-3. View

19.

Ridgway D . The first 1000 dendritic cell vaccinees. Cancer Invest. 2004; 21(6):873-86. DOI: 10.1081/cnv-120025091. View

20.

Lotz M, Vaughan J, Carson D . Effect of neuropeptides on production of inflammatory cytokines by human monocytes. Science. 1988; 241(4870):1218-21. DOI: 10.1126/science.2457950. View